Results 101 to 110 of about 2,418,826 (273)

Peripheral CA 125 levels in patients with uterine fibroids.

open access: yes, 1992
CA 125, a marker of ovarian cancer, is also increased in otherwise normal women suffering from, for example, pelvic inflammatory disease, endometriosis and adenomyosis.
Bischof P   +4 more
core   +1 more source

The Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study

open access: yesGastroenterology Research and Practice, 2015
Objective. To investigate the serum level of CA-125 and its corresponding clinical significance in Chinese patients with primary BCS. Methods. Serum CA-125 was measured in 243 patients with primary BCS receiving interventional treatment in the ...
De-lei Cheng   +5 more
doaj   +1 more source

Biodegradable 3D‐Printable and Coatable Antifouling Composites for Marine Applications

open access: yesAdvanced Functional Materials, EarlyView.
Marine biofouling damages submerged surfaces and raises greenhouse gas emissions. Biodegradable antifouling biocomposites were developed by hot‐mixing beeswax, Tween 80, and calcium stearate or stearic acid. Adjusting the component ratio enables processing via hot‐pressing, 3D‐printing, or dip‐coating.
Gabriele Corigliano   +17 more
wiley   +1 more source

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

open access: yesAdvanced Healthcare Materials, EarlyView.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj   +23 more
wiley   +1 more source

Intelligent Orthopedics: Machine Learning in Diagnosis of Bone Disease, Implants, and Bone Health Monitoring

open access: yesAdvanced Healthcare Materials, EarlyView.
Efficient recovery from traumatic or degenerative diseases is a great challenge, even after all the advancements in bone and cartilage regeneration. Machine learning (ML) algorithms have presented opportunities to enhance these aspects by accurately analyzing imaging data.
Maryam Kamaei   +9 more
wiley   +1 more source

Annali di Ca’ Foscari. Serie orientale (2014-)

open access: yes
Attiva da oltre quarant\u27anni con periodicità annuale, la rivista è espressione del Dipartimento di Studi sull\u27Asia e sull\u27Africa Mediterranea dell’Università Ca’ Foscari di Venezia.

core  

Carcinoembryonic Antigen (CEA), α-fetoprotein, CA 19.9 and CA 125 in Advanced Colorectal Cancer (ACC)

open access: yes, 1993
In 111 patients with ACC we studied CEA, FP, CA-125 and CA 19.9 during therapy and follow-up. Marker determination was performed every two months. CEA was elevated (> 5 ng/ml) in 82%, αFP(> 15 ng/ml) in 0%, CA-125 (>38 U/ml) in 37%, CA 19.9 ...
H. Tsoutsos   +7 more
core   +1 more source

CA 125 Elevation Due to Minimal Change Disease

open access: yesTurkish Journal of Nephrology, 2019
Minimal change disease is a glomerular disease that can be primary or secondary and accounts for %10- 15 percent of adult nephrotic syndrome cases.
İlter BOZACI   +3 more
doaj  

Advancing Human Skin Equivalents: The Crucial Role of Neurovascular Integration

open access: yesAdvanced Healthcare Materials, EarlyView.
This review discusses the importance of integrating vascular and peripheral nerve systems into human skin equivalents (HSEs) to better recapitulate native skin physiology. Recent advances in vascularized, innervated, and neurovascularized HSEs are highlighted, together with emerging bioengineering strategies, current challenges, and future ...
Hao Wu   +4 more
wiley   +1 more source

Serum CA 125 as a Marker of Hepatocellular Carcinoma

open access: yes, 1996
This study was undertaken to investigate whether serum CA 125 could complement alpha-fetoprotein (AFP) to improve the diagnosis of hepatocellular carcinoma (HCC).
M. Balasegaram   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy